We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.6%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$6.61B
AUM Growth
+$398M
(+6.4%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
15.55%
Holding
1,373
New
121
Increased
405
Reduced
579
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$17.2M |
| 2 |
AEGR
Aegerion Pharmaceuticals
AEGR
|
+$14M |
| 3 |
PepsiCo
PEP
|
+$12.7M |
| 4 |
Apple
AAPL
|
+$11.7M |
| 5 |
GE Aerospace
GE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flowserve
FLS
|
+$13.3M |
| 2 |
Xylem
XYL
|
+$13M |
| 3 |
Microsoft
MSFT
|
+$12.4M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$12.2M |
| 5 |
SPX Corp
SPXC
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.88% |
| 2 | Technology | 13.2% |
| 3 | Industrials | 12.57% |
| 4 | Financials | 12.22% |
| 5 | Consumer Staples | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Trane Technologies
TT
$98.8B
| $8.1M | 0.12% |
131,453
+28,482
| +28% | +$1.57M |
|
227
Norfolk Southern
NSC
$75.4B
| $8.09M | 0.12% |
87,137
-8,570
| -9% | -$735K |
|
228
Aflac
AFL
$65.5B
| $7.97M | 0.12% |
238,522
+73,874
| +45% | +$2.42M |
|
229
Crown Castle
CCI
$34.6B
| $7.97M | 0.12% |
108,505
+10,888
| +11% | +$806K |
|
230
Banco Santander Chile
BSAC
$16.1B
| $7.95M | 0.12% |
337,357
+12,779
| +4% | +$303K |
|
231
FedEx
FDX
$73B
| $7.88M | 0.12% |
54,839
+22,381
| +69% | +$2.96M |
|
|
OCR
232
DELISTED
OMNICARE INC
OCR
| $7.85M | 0.12% |
130,039
+37,474
| +40% | +$2.15M |
|
233
Boston Scientific
BSX
$68.4B
| $7.78M | 0.12% |
647,233
+148,853
| +30% | +$1.76M |
|
|
VWTR
234
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $7.78M | 0.12% |
336,602
-104,257
| -24% | -$2.44M |
|
235
NVIDIA
NVDA
$4.6T
| $7.73M | 0.12% |
19,292,000
+1,852,200
| +11% | +$717K |
|
|
QVCGA
236
DELISTED
QVC Group Inc Series A
QVCGA
| $7.58M | 0.11% |
6,293
-417
| -6% | -$464K |
|
237
Tapestry
TPR
$30.3B
| $7.55M | 0.11% |
134,494
+31,562
| +31% | +$1.71M |
|
238
Liberty Global Class A
LBTYA
$3.59B
| $7.54M | 0.11% |
205,329
+13,376
| +7% | +$448K |
|
|
ALXN
239
DELISTED
Alexion Pharmaceuticals
ALXN
| $7.52M | 0.11% |
56,560
+10,777
| +24% | +$1.29M |
|
|
AEGN
240
DELISTED
Aegion Corp
AEGN
| $7.4M | 0.11% |
338,255
+258,588
| +325% | +$5.61M |
|
241
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1B
| $7.33M | 0.11% |
227,800
-25,000
| -10% | -$799K |
|
242
Allstate
ALL
$70.6B
| $7.26M | 0.11% |
133,138
-150,926
| -53% | -$8.05M |
|
243
PG&E
PCG
$39B
| $7.23M | 0.11% |
179,537
+86,098
| +92% | +$3.53M |
|
244
SLM Corp
SLM
$4.83B
| $7.2M | 0.11% |
766,297
-8,707
| -1% | -$80.1K |
|
|
PRE
245
DELISTED
PARTNERRE LTD
PRE
| $7.12M | 0.11% |
67,544
+25,234
| +60% | +$2.48M |
|
246
Applied Materials
AMAT
$347B
| $7.12M | 0.11% |
402,454
-35,229
| -8% | -$614K |
|
247
Edison International
EIX
$30.3B
| $7.05M | 0.11% |
152,356
+109,155
| +253% | +$5.16M |
|
248
Ashland
ASH
$3.34B
| $7.01M | 0.11% |
147,753
-133,563
| -47% | -$5.97M |
|
249
International Paper
IP
$22.6B
| $7M | 0.11% |
152,865
+20,523
| +16% | +$878K |
|
250
Host Hotels & Resorts
HST
$17.5B
| $6.97M | 0.11% |
358,573
+14,801
| +4% | +$273K |
|
Similar funds
HF
KBC Group's Q4 2013 Portfolio in Review
As of Q4 2013, KBC Group held 1,373 positions worth $6.61B, up 6.4% from $6.21B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
KBC Group withdrew a net $226M in Q4 2013, closing 55 positions and reducing 579 holdings. Its most notable exit was Steris, an estimated $5.72M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
Against the trend, KBC Group opened a new position in Aegerion Pharmaceuticals worth $13M.
- KBC Group's largest Q4 2013 buy was Aegerion Pharmaceuticals: 183,492 shares worth $13M.
- KBC Group added most to EOG Resources in Q4 2013, an estimated $17.2M increase.
- KBC Group's biggest Q4 2013 reduction was Flowserve, cutting an estimated $13.3M.
- KBC Group fully exited Steris in Q4 2013, selling an estimated $5.72M.
- KBC Group's ten largest holdings make up 16% of its $6.61B portfolio in Q4 2013.
- KBC Group opened 121 new positions and closed 55 in Q4 2013.
- KBC Group's portfolio value rose 6.4% quarter-over-quarter to $6.61B.
Based on KBC Group's 13F filing for Q4 2013, filed 21 Jan 2014.